An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)
Part of paid clinical trials in Chino, California.
- Sponsor
- Seaport Therapeutics
- Study ID
- NCT07161700
- Phase
- PHASE2
- Status
- Enrolling By Invitation
Conditions
- Major Depressive Disorder (MDD)
- Major Depressive Disorder With Anxious Distress
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 66 Years
- Healthy Volunteers
- Not accepted
Interventions
- SPT-300 — DRUGA prodrug of allopregnanolone, a small molecule drug
Study Details
This is an open-label, monotherapy, extension study to evaluate the safety and tolerability of SPT-300 (GlyphAllo) in adults with major depressive disorder (MDD), with or without anxious distress.
Key Dates
- Start date
- Sep 2, 2025
- Status verified
- May 2026
- Primary completion
- May 31, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 360 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: SPT-300Participants will receive SPT-300 capsules once daily for 42 days
Primary Outcome Measure
Safety and tolerability assessments based on Treatment-emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs) and validated clinical scales and procedures [ Time Frame: Up to Day 49 ]
Locations (13)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Seaport Investigator Site | Chino | California | 91710 | - |
| Seaport Investigator Site | Garden Grove | California | 92845-2506 | - |
| Seaport Investigator Site | Glendale | California | 91206 | - |
| Seaport Investigator Site | West Palm Beach | Florida | 33407 | - |
| Seaport Investigator Site | Atlanta | Georgia | 30328 | - |
| Seaport Investigator Site | Decatur | Georgia | 30030 | - |
| Seaport Investigator Site | Boston | Massachusetts | 02116 | - |
| Seaport Investigator Site | St Louis | Missouri | 63141 | - |
| Seaport Investigator Site | Brooklyn | New York | 11235 | - |
| Seaport Investigator Site | New York | New York | 10029 | - |
| Seaport Investigator Site | Staten Island | New York | 10314 | - |
| Seaport Investigator Site | North Canton | Ohio | 44720 | - |
| Seaport Investigator Site | Irving | Texas | 75062 | - |
Find similar trials in Chino, CA
Related Studies
- A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderPHASE3 · Recruiting · Cybin IRL Limited · Birmingham, Alabama
- Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive DisorderPHASE3 · Recruiting · Vanda Pharmaceuticals · Phoenix, Arizona
- Orexin Antagonism for Suicide Risk: A Proof-of-Concept Clinical TrialPHASE2 · Recruiting · Marianne Goodman · The Bronx, New York
- Home-Based tDCS Treatment Of Major Depressive DisorderRecruiting · Sooma Medical Inc · Boston, Massachusetts